Esofagite eosinofílica: um conceito em evolução?
Eosinophilic esophagitis: an evolving concept?
Fernanda Marcelino da Silva Veiga; Ana Paula Beltran Moschione Castro; Cristiane de Jesus Nunes dos Santos; Mayra de Barros Dorna; Antonio Carlos Pastorino
Resumo
O objetivo deste artigo é revisar a literatura dos últimos 10 anos sobre esofagite eosinofílica (EoE) e descrever os conceitos atuais da doença em seus aspectos de definição, fisiopatologia, fatores de risco, quadro clínico, diagnóstico e tratamento. Foram pesquisados artigos na base de dados do PubMed, do Bireme/ LILACS e do SciELO, nos últimos 10 anos. Os critérios para a inclusão dos artigos foram: (a) publicação nos últimos 10 anos, (b) artigos originais, (c) apenas humanos, (d) artigos de revisão, (e) diretrizes. Os critérios de exclusão foram: (a) artigos que não continham como tema principal a EoE, (b) artigos repetidos, (c) descrição de casos, (d) artigos com abordagem muito específicas para tratamento e diagnóstico. Foi realizada leitura dos resumos por dois pesquisadores, e posterior seleção dos artigos completos para a leitura. Foram acrescentados estudos que aprofundavam aspectos cruciais da revisão, sendo incluídos, ao todo, 3 consensos, 35 estudos e 3 artigos de revisão, que constituíram o total de artigos analisados. A conclusão é de que a EoE é uma doença crônica, cujos aspectos clínicos são fundamentais para a suspeita diagnóstica, mas requer a associação de achados endoscópicos e histológicos para sua confirmação. Na última década, houve modificações significativas nos critérios diagnósticos e algumas novas recomendações no tratamento, mas que necessitam uma observação em longo prazo.
Palavras-chave
Abstract
The objective of this paper was to review literature on eosinophilic esophagitis (EoE) published over the last 10 years and to describe current disease concepts related to definition, pathophysiology, risk factors, clinical presentation, diagnosis and treatment. We searched the PubMed, Bireme/LILACS and SciELO databases for articles published in the last 10 years. The following inclusion criteria were used to select articles: (a) publication in the last 10 years; (b) original articles; (c) studies with humans only; (d) review articles; (e) guidelines. Exclusion criteria were: (a) articles that did not have EoE as the main subject; (b) repeated articles; (c) case reports; (d) articles addressing a very specific treatment or diagnostic technique. Abstracts were screened by two investigators, and articles meeting the criteria were selected for full-text reading. Any relevant studies addressing crucial aspects of the review were added to the sample, resulting in a total of 3 consensus articles, 35 original articles, and 3 review articles. The review showed that EoE is a chronic disease in which clinical aspects are essential for diagnostic suspicion, but associated endoscopic and histological findings are required to confirm diagnosis. Over the last 10 years, significant changes were observed in diagnostic criteria, and some new treatment recommendations emerged, however still requiring long-term follow-up.
Keywords
References
1. Landres RT, Kuster GGR, Strum WB. Eosinophilic esophagitis in a patient with vigorous achalasia. Gastroenterology. 1978;74:1298‑301.
2. Attwood SEA, Smyrk TC, DeMeester TR, et al. Esophageal eosinophilia with dysphagia: a distinct clinicopathological syndrome. Dig Dis Sciences. 1993;38:109-16.
3. Spergel JM, Brown-Whitehorn TF, Beausoleil JL, et al. 14 years of eosinophilic esophagitis: clinical features and prognosis. J Pediatr Gastroenterol Nutr. 2009;48:30-6.
4. Moawad FJ, Veerappan GR, Lake JM, et al. Correlation between eosinophilic esophagitis and aeroallergens. Aliment Pharmacol Ther. 2010;31:509-15.
5. Hruz P, Straumann A, Bussmann C, Heer P, Simon HU, Zwahlen MM, et al. Escalating incidence of eosinophilic esophagitis: a 20-year prospective, population-based study in Olten County, Switzerland. J Allergy Clin Immunol. 2011;128:1349-50.
6. Sperry SL,Woosley JT,Shaheen NJ, et al. Influence of race and gender on the presentation of eosinophilic esophagitis. Am J Gastroenterol. 2012;107:215-21.
7. Moawad FJ, Veerappan GR, Dias JA, et al. Race may play a role in the clinical presentation of eosinophilic esophagitis. Am J Gastroenterol. 2012;107:1263.
8. Dellon ES. Epidemiology of eosinophilic esophagitis. Gastroenterol Clin North Am. 2014;43:201-18.
9. D’Alessandro A, Esposito D, Pesce M, Cuomo R, Palma GD, Sarnelli G. Eosinophilic esophagitis: from pathophysiology to treatment. World J Gastrointest Pathophysiol. 2015;6(4):150-8.
10. Liacouras CA, Furuta GT, Hirano I, Atkins D, Attwood SE, Bonis PA, et al. Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol. 2011;128:3-20.
11. Singla MB, Moawad FJ. An overview of the diagnosis and management of eosinophilic esophagitis. Clin Transl Gastroenterol. 2016;7:e155.
12. Furuta GT, Liacouras CA, Collins MH, et al. Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology. 2007;133:1342-63.
13. Lucendo AJ, Molina-Infante J, Arias A, von Arnim U, Bredenoord AJ, Bussmann C, et al. Guidelines on eosinophilic esophagitis: evidence-based statements and recommendations for diagnosis and management in children and adult. United European Gastroenterol J. 2017;5(3):335-58.
14. Dellon ES, Gonsalves N, Hirano I, Furuta GT, Liacouras CA, Katzka DA. Clinical guideline: evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE). Am J Gastroenterol. 2013;108:679-92.
15. Jensen E, Hoffman K, Shaheen NJ, Genta RM, Dellon ES. Esophageal eosinophilia is increased in rural areas with low population density: results from a national pathology database. Am J Gastroenterol. 2014;109:668-75.
16. Jensen ET, Kappelman MD, Kim HP, Ringel-Kulka T, Dellon ES. Early life exposures as risk factors for pediatric eosinophilic esophagitis. J Pediatr Gastroenterol Nutr. 2013;57:67-71.
17. Blanchard C, Wang N, Stringer KF, Mishra A, Fulkerson PC, Abonia JP, et al. Eotaxin-3 and a uniquely conserved gene expression profile in eosinophilic esophagitis. J Clin Invest. 2006;116:536-47.
18. Fujiwara H, Morita A, Kobayashi H, Hamano K, Fujiwara Y, Hirai K, et al. Infiltrating eosinophils and eotaxin: their association with idiopathic eosinophilic esophagitis. Ann Allergy Asthma Immunol. 2002;89:429-32.
19. Blanchard C, Stucke EM, Burwinkel K, Caldwell JM, Collins MH, Ahrens A, et al. Coordinate interaction between IL-13 and epithelial differentiation cluster genes in eosinophilic esophagitis. J Immunol. 2010;184:4033-41.
20. Spergel JM. An Allergist’s perspective to the evaluation of eosinophilic esophagitis. Best Pract Res Clin Gastroenterol. 2015;29(5):771‑81.
21. Sherrill JD, Kc K, Wu D, et al. Desmoglein-1 regulates esophageal epithelial barrier function and immune responses in eosinophilic esophagitis. Mucosal Immunol. 2014;7:718-29.
22. Travers J, Rothenberg ME. Eosinophils in mucosal immune responses. Mucosal Immunol. 2015;8:464-75.
23. Gleich GJ, Frigas E, Loegering DA, Wassom DL, Steinmuller D. Cytotoxic properties of the eosinophil major basic protein. J Immunol. 1979;123:2925-27.
24. Dellon ES. Eosinophilic esophagitis: Diagnostic tests and criteria. Curr Opin Gastroenterol. 2012;28(4):382-8.
25. Furuta GT, Katzka DA. Eosinophilic esophagitis. N Engl J Med. 2015;373:1640-8.
26. Wen T, Dellon ES, Moawasa FJ, Furuta GT, et al. Transcriptome analysis of PPI-REE reveals PPI-reversible allergic inflammation. J Allergy Clin Immunol. 2015;135:187-97.
27. Allen BC, Baker ME, Falk GW. Role of barium esophagography in evaluating dysphagia. Cleve Clin J Med. 2009;76:105-11.
28. Gentile N, Katzka D, Ravi K, et al. Oesophageal narrowing is common and frequently under-appreciated at endoscopy in patients with oesophageal eosinophilia. Aliment Pharmacol Ther. 2014;40:1333‑40.
29. Menard-Katcher C, Swerdlow MP, Mehta P, Furuta GT, Fenton LZ. Contribution of esophagram to the evaluation of complicated pediatric eosinophilic esophagitis. J Pediatr Gastroenterol Nutr. 2015;61(5):541-6.
30. Spergel JM, Beausoleil JL, Mascarenhas M, et al. The use of skin prick tests and patch tests to identify causative foods in eosinophilic esophagitis. J Allergy Clin Immunol. 2002;109(2):363-8.
31. Spergel JM, Andrews T, Brown-Whitehorn TF, et al. Treatment of eosinophilic esophagitis with specific food elimination diet directed by a combination of skin prick and patch tests. Ann Allergy Asthma Immunol. 2005;95(4):336-43.
32. Spergel JM, Brown-Whitehorn TF, Cianferoni A, et al. Identification of causative foods in children with eosinophilic esophagitis treated with an elimination diet. J Allergy Clin Immunol. 2012;130(2):461-7.
33. Simon D, Straumann A, Wenk A, et al. Eosinophilic esophagitis in adults - no clinical relevance of wheat and rye sensitizations. Allergy. 2006;61(12):1480-3.
34. Molina-Infante J, Martin-Noguerol E, Alvarado-Arenas M, Porcel-Carreño SL, Jimenez-Timon S, Hernandez-Arbeiza FJ. Selective elimination diet based on skin testing has suboptimal efficacy for adult eosinophilic esophagitis. J Allergy Clin Immunol. 2012;130(5):1200-2.
35. Wolf WA, Jerath MR, Sperry SL, Shaheen NJ, Dellon ES. Dietary elimination therapy is an effective option for adults with eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2014;12(8):1272-9.
36. Arias A, Gonzalez-Cervera J, Tenias JM, Lucendo AJ. Efficacy of dietary interventions for inducing histologic remission in patients with eosinophilic esophagitis: a systematic review and meta-analysis. Gastroenterology. 2014;146(7):1639-48.
37. Molina-Infante J, Gisbert JP. Letter: PPI-responsive oesophageal eosinophilia – from initial scepticism to consistent prospective data. Aliment Pharmacol Ther. 2014;39:229-30.
38. Aceves SS, Bastian JF, Newbury RO, Dohil R. Oral viscous budesonide: a potential new therapy for eosinophilic esophagitis in children. Am J Gastroenterol. 2007;102:2271-9.
39. Aceves SS, Dohil R, Newbury RO, Bastian JF. Topical viscous budesonide suspension for treatment of eosinophilic esophagitis. J Allergy Clin Immunol. 2005;116:705-6.
40. Moawad FJ, Cheatham JG, DeZee KJ. Meta-analysis: the safety and efficacy of dilation in eosinophilic oesophagitis. Aliment Pharmacol Ther. 2013;38:713-20.
41. Sayei WN, Patel R, Backer RD, Tron E, Backer SS. Treatment with high-dose proton pump inhibitors helps distinguish eosinophilic esophagitis from noneosinophilic esophagitis. Journal of Pediatric Gastroenterology and Nutrition. 2009;49:393-9.
Submitted date:
08/28/2017
Accepted date:
10/02/2017
Facebook
LinkedIn
Mendeley
StumbleUpon
Reddit
Email